December 13, 2010
This week at Pharmtech, Arun Kumar, Vice President and Head of the Global Life Sciences Business Unit at Infosys, an IT, business and consulting firm, discussed how the cloud is shaping the pharmaceutical industry--and what is coming in 2011. Read more…
October 25, 2010
In terms of enterprise HPC cloud adoption, the pharmaceutical industry is a relative leader due to its need to reduce time to market via the on-demand, scalable access to resources on a pay-as-you-go basis. The computational strategies are well-suited to cloud in other ways as well, as CloudSwitch founder Ellen Rubin explains. Read more…
May 11, 2010
With the recent FDA rulings governing how sales can interact with doctors, the importance of a CRM system to track the complex customer interactions has never been more critical. Read more…
Whether an organization chooses a cloud for general business needs or a highly tailored workload, the spectrum of offerings and configurations can be overwhelming. To help you navigate the various cloud options available today, we're breaking down your options, exploring pros and cons, and sharing ways to keep your options open and your business agile as you execute your cloud strategy.
Researchers in academic labs and commercial R&D groups continue to need more compute capacity, which means leveraging the latest innovations in HPC technologies as well as an assortment of resources to meet the unique needs of different workloads. Increasingly, systems based on Arm processors are stepping into that role, offering low power consumption and strategic advantages for HPC workloads.
Whether it's for fraud detection, personalized medicine, manufacturing, smart cities, autonomous vehicles and many other areas, advanced-scale computing has exploded beyond the realm of academia and government and into the private sector. And with data-intensive workloads on the rise, commercial users are turning to HPC-based infrastructure to run the AI, ML and cognitive computing applications that their organizations depend on.
© HPCwire. All Rights Reserved. A Tabor Communications Publication
Reproduction in whole or in part in any form or medium without express written permission of Tabor Communications, Inc. is prohibited.